$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Is Adagrasib (Krazati) prone to causing diarrhea and sharing of experience in dealing with side effects?
2026-02-01 22:25:32
Check Details
Detailed description of contraindications and inapplicable groups of larotrectinib (Vitakai)
2026-02-01 22:25:32
Check Details
Analysis of the clinical efficacy of Selinisol (Silvio) in the treatment of multiple myeloma
2026-02-01 22:25:32
Check Details
Which company produces Vigabatrin and its production background?
2026-02-01 22:25:32
Check Details
Analysis of items that require regular inspection during treatment with Mobosetinib (Anvili)
2026-02-01 22:25:32
Check Details
Efficacy and patient cases of Tepotinib (Tuodekang) in the treatment of MET mutated gastric cancer
2026-02-01 22:25:32
Check Details
Suggestions and price comparison on domestic and imported versions of Regorafenib
2026-02-01 22:25:32
Check Details
Can patients with intestinal cancer take pazopanib (Vita) and analysis of its efficacy
2026-02-01 22:25:32
Check Details
Opicapone drug interactions and precautions for combined use
2026-02-01 22:25:32
Check Details
The most reasonable number of Finerenone tablets 10mg per day and dosage instructions
2026-02-01 22:25:32
Check Details
Rasagiline (Azilai) medication time recommendations and daily medication guidance
2026-02-01 22:25:32
Check Details
Chemical structural characteristics and drug development background of eflornithine (IWILFIN)
2026-02-01 22:25:32
Check Details
1
2
...
1982
1983
1984
1985
1986
1987
1988
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma